Neurogene
NGNE
NGNE
81 hedge funds and large institutions have $330M invested in Neurogene in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $417M → $330M (-$87.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
57% less call options, than puts
Call options by funds: $156K | Put options by funds: $367K
Holders
81
Holding in Top 10
2
Calls
$156K
Puts
$367K
Top Buyers
| 1 | +$6.1M | |
| 2 | +$5.9M | |
| 3 | +$5.09M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$4.45M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.92M |
Top Sellers
| 1 | -$8.92M | |
| 2 | -$4.77M | |
| 3 | -$2.44M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.31M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.21M |